1
Pratik Devasthale, William N Washburn, Kishore V Renduchintala, Radhakrishnan Sridhar: Azolotriazinone melanin concentrating hormone receptor-1 antagonists. Bristol Myers Squibb Company, Jing G Sun, Burton Rodney, November 12, 2013: US08580959 (4 worldwide citation)

The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein the variables are defined herein.


2
Sheldon Hiebert, Ramkumar Rajamani, Li Qiang Sun, Eric Mull, Eric P Gillis, Michael S Bowsher, Qian Zhao, Nicholas A Meanwell, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, P V K Suresh Babu, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, February 17, 2015: US08957203 (1 worldwide citation)

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


3
Pulicharla Nagalakshmi, Kandhasamy Sarkunam, Kishore V Renduchintala, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, February 28, 2017: US09580463

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


4
Li Qiang Sun, Qian Zhao, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, Eric P Gillis, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, May 9, 2017: US09643999

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


5
Sheldon Hiebert, Ramkumar Rajamani, Li Qiang Sun, Eric Mull, Eric P Gillis, Michael S Bowsher, Qian Zhao, Nicholas A Meanwell, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, P V K Suresh Babu, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, December 27, 2016: US09527885

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


6
Ramkumar Rajamani, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, Nicholas A Meanwell, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, April 8, 2014: US08691757

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


7
Pratik Devasthale, William N Washburn, Kishore V Renduchintala, Radhakrishnan Sridhar: Azolotriazinone melanin concentrating hormone receptor-1 antagonists. Bristol Myers Squibb Company, Jing G Sun, Burton Rodney, June 17, 2014: US08754211

The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein the variables are defined herein.


8
Pratik Devasthale, William N Washburn, Kishore V Renduchintala, Radhakrishnan Sridhar: Azolotriazinone melanin concentrating hormone receptor-1 antagonists. September 8, 2011: US20110218185-A1

The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein the variables are defined herein.